LPCUF (Lee's Pharmaceutical Holdings) Price-to-Tangible-Book : 1.68 (As of May. 12, 2025)

View and export this data going back to 2014. Start your Free Trial

What is Lee's Pharmaceutical Holdings Price-to-Tangible-Book?

As of today (2025-05-12), Lee's Pharmaceutical Holdings's share price is $0.1882. Lee's Pharmaceutical Holdings's Tangible Book per Share of Dec. 2024 for the quarter that ended in Dec. 2024 was $0.11. Hence, Lee's Pharmaceutical Holdings's Price to Tangible Book Ratio of today is 1.68.

The historical rank and industry rank for Lee's Pharmaceutical Holdings's Price-to-Tangible-Book or its related term are showing as below:

LPCUF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.94 Med: 1.89 Max: 5.12
Current: 1.57

During the past 13 years, Lee's Pharmaceutical Holdings's highest Price to Tangible Book Ratio was 5.12. The lowest was 0.94. And the median was 1.89.

LPCUF's Price-to-Tangible-Book is ranked better than
66.59% of 835 companies
in the Drug Manufacturers industry
Industry Median: 2.23 vs LPCUF: 1.57

A closely related ratio is called PB Ratio. As of today, Lee's Pharmaceutical Holdings's share price is $0.1882. Lee's Pharmaceutical Holdings's Book Value per Sharefor the quarter that ended in Dec. 2024 was $0.36. Hence, Lee's Pharmaceutical Holdings's P/B Ratio of today is 0.52.

Lee's Pharmaceutical Holdings Price-to-Tangible-Book Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings Price-to-Tangible-Book Chart

Lee's Pharmaceutical Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Tangible-Book

Get a 7-Day Free Trial

4.04

3.43

1.02

0.96

1.68

Lee's Pharmaceutical Holdings Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Price-to-Tangible-Book	Get a 7-Day Free Trial															1.02	0.99	0.96	1.46	1.68

Competitive Comparison of Lee's Pharmaceutical Holdings's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lee's Pharmaceutical Holdings's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Lee's Pharmaceutical Holdings's Price-to-Tangible-Book falls into.

Save Embed

;

Save Embed

;

Lee's Pharmaceutical Holdings Price-to-Tangible-Book Calculation

Lee's Pharmaceutical Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2024 )
	=	0.1882	/	0.112
	=	1.68

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Lee's Pharmaceutical Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Lee's Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (OTCPK:LPCUF) » Definitions » Price-to-Tangible-Book

Traded in Other Exchanges

00950:Hong Kong

Address

Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG

Website

https://www.leespharm.com

Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Lee's Pharmaceutical Holdings Headlines

No Headlines